Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- BULLETIN
August 25, 2003
- Effects of Triptan-type Migraine Drugs Differ by Patient
August 25, 2003
- BUSINESS NEWS IN BRIEF
August 25, 2003
- JPMA's R&D Committee to Focus on Pharmacogenomics: New Chairman
August 25, 2003
- Yonyaku to Bolster Alliance with Nakazawa Ujike
August 25, 2003
- NEW PRODUCTS
August 25, 2003
- API to Expand Contract Mfg of Investigational, Bulk Drugs
August 25, 2003
- Kirin Licenses Human Antibody Technology to Takeda
August 11, 2003
- Aventis' Ketek, Japan's 1st Ketolide Approved
August 11, 2003
- Evotec Neuroscience, Takeda to Collaborate in Drug Discovery for Alzheimer's Disease
August 11, 2003
- BUSINESS NEWS IN BRIEF
August 11, 2003
- Planning to Apply for 20 Drugs by 2006: Mr McKinnell of Pfzier
August 11, 2003
- MEDICAL DEVICE NEWS IN BRIEF
August 11, 2003
- DIAGNOSTIC NEWS IN BRIEF
August 11, 2003
- NEW PRODUCTS
August 11, 2003
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
August 11, 2003
- Warning against Facile Use of Antibiotics to Treat Colds: JRS GL
August 11, 2003
- AnGes MG Granted Patent Rights on HGF Gene Therapy
August 11, 2003
- Sosei Raises \1.6 Billion to Finance Development
August 11, 2003
- Part of Revised PAL Goes into Effect on July 30
August 11, 2003
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…